Tech And Healthcare Lead Friday Sectors Lower As Growth Stocks Retreat
By The Online Investor Staff, Friday, March 27, 2:33 PM ETToday's weakness in Technology & Communications continues a recent rotation away from higher-growth, higher-valuation names and toward more defensive or cash-generative parts of the market. Rising interest-rate expectations and concerns about the durability of earnings growth in software, digital infrastructure, and crypto-exposed businesses have made investors more sensitive to valuation risk. For many technology companies, a significant portion of their perceived value comes from cash flows expected several years in the future; when discount rates move higher, those future cash flows are worth less in present-value terms, which can pressure share prices.
Within the group, Datadog Inc is emblematic of software-as-a-service names that had seen substantial multiple expansion over the past few years. The stock's year-to-date decline reflects a combination of profit-taking in prior winners, increased competition in observability and cloud-monitoring tools, and investor scrutiny of growth rates relative to rich valuations. Coinbase Global Inc, by contrast, is more closely tied to sentiment in digital-asset markets. Its share performance has been particularly volatile, as equity investors react not only to spot cryptocurrency prices and transaction volumes on the platform, but also to an evolving regulatory backdrop for crypto trading and custody in the United States and abroad. Periods of lower trading activity or heightened legal and policy uncertainty can weigh heavily on COIN even when the broader technology sector is mixed.
ETF investors may take some comfort from the diversification inherent in XLK, which holds a broad basket of large-cap technology and communications names across subsectors such as semiconductors, software, hardware, and networking. However, as a capitalization-weighted fund, XLK remains sensitive to moves in its largest constituents, and broad sector pullbacks tend to be reflected quickly in its price. For long-term investors, sector drawdowns such as today's can present opportunities to reassess exposures, rebalance portfolios back toward strategic targets, or add selectively to high-conviction names on weakness, while remaining mindful of concentration risk and valuation discipline.
The next worst performing sector is the Healthcare sector, showing a 1.8% loss. Among large Healthcare stocks, Align Technology Inc (NASDAQ:ALGN) and Moderna Inc (NASDAQ:MRNA) are the most notable, showing a loss of 7.3% and 5.3%, respectively. One ETF closely tracking Healthcare stocks is the Health Care Select Sector SPDR ETF (XLV), which is down 1.1% in midday trading, and down 6.47% on a year-to-date basis. Align Technology Inc, meanwhile, is up 5.31% year-to-date, and Moderna Inc is up 71.96% year-to-date. Combined, ALGN and MRNA make up approximately 0.6% of the underlying holdings of XLV, so their single-day moves have only a modest direct effect on the ETF's performance.
Healthcare's decline today comes despite its traditional role as a relatively defensive sector during periods of market stress. The move suggests that investors are reassessing not only cyclically sensitive industries, but also higher-beta, innovation-focused health names such as medical-device makers and biotechnology companies. Align Technology, which develops clear aligner systems and other dental technologies, can be sensitive to consumer discretionary spending trends and global procedure volumes; concerns about slowing demand or competitive pressures can amplify downside moves on days when growth stocks are broadly under pressure. Moderna, whose profile rose sharply during the COVID-19 pandemic on the back of its mRNA vaccine platform, has experienced substantial share-price volatility as investors evaluate the sustainability of its post-pandemic revenue base, the timing and probability of success for its vaccine and therapeutic pipeline, and ongoing research and development spending.
For ETF allocators, XLV provides diversified exposure to pharmaceuticals, biotechnology, managed care, medical equipment, and related industries, and typically carries a risk profile that is lower than that of concentrated single-stock positions. Nonetheless, the sector remains exposed to policy developments around drug pricing, reimbursement frameworks, and regulatory approvals, as well as to the innovation cycle in biotechnology. Periods of sector-wide weakness offer investors an occasion to revisit their assumptions about long-term healthcare demand, demographic trends, and the balance between defensive earnings characteristics and stock-specific pipeline risk.
Start slideshow:Comparing these stocks and ETFs on a trailing twelve month basis, below is a relative stock price performance chart, with each of the symbols shown in a different color as labeled in the legend at the bottom. Relative charts of this kind allow investors to see at a glance which names have outperformed or lagged over the period, beyond the noise of single-session moves. A name that is sharply lower today may still be a significant outperformer over the past year, while a modest decline in a previously weak stock can look different in that longer-term context. Such comparisons can be useful for investors evaluating whether current pullbacks represent potential buying opportunities in structural winners, or further evidence of deteriorating trends in persistently weak names.
From a broader asset-allocation perspective, the divergence across sectors today highlights the importance of maintaining diversification rather than attempting to time short-term rotations. While Technology & Communications and Healthcare are under pressure, areas such as Energy and Utilities are advancing, reflecting different sensitivities to interest rates, commodity prices, and economic growth expectations. Investors who build portfolios aligned with long-term objectives and risk tolerance, and then rebalance periodically, may be better positioned to navigate days when leadership rotates sharply across sectors.
Here's a snapshot of how the S&P 500 components within the various sectors are faring in afternoon trading on Friday. As you can see, four sectors are up on the day, while five sectors are down.
| Sector | % Change |
|---|---|
| Energy | +1.6% |
| Utilities | +1.2% |
| Consumer Products | +0.5% |
| Materials | +0.1% |
| Financial | -1.3% |
| Industrial | -1.5% |
| Services | -1.6% |
| Healthcare | -1.8% |
| Technology & Communications | -2.1% |
Scan the next set of investor ideas in Current Top Analyst Picks of the S&P 500, with a focus on names tied to the same market theme.
